Where Are We Now?: The Changing Role of Pharmacists in the COVID-19 Treatment Landscape | PTCE Connect Podcast

 Lisa Dumkow, PharmD, BCIDP, Antimicrobial Stewardship Clinical Pharmacist, PGY-2 Infectious Diseases Pharmacy Residency Program Director, Mercy Health Saint Mary’s, Grand Rapids, MI Lacy Worden, PharmD, PGY-2 Infectious Diseases Pharmacy resident, Mercy Health Saint Mary’s, Grand Rapids MI [LP1]  Dr. Dumkow & Dr. Worden have no relevant financial relationships with commercial interests to disclose PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour of knowledge-based credit. This activity is supported by educational grants from GlaxoSmithKline.     The educational objectives for this activity are: o  Examine important milestones and recent updates in the treatment and management of COVID-19 o  Interpret safety and efficacy data for recently approved, authorized, or investigational agents for the treatment of COVID-19 o  Illustrate how pharmacists can assist with educating patients and other health care providers regarding the latest updates to the treatment of COVID-19 Summary statement of topic being discussed: This is a conversational interview which will focus on emerging therapies for the management of COVID-19 in the outpatient setting. A discussion around current and investigational therapies will be covered. Key takeaways and practical points will be the focus. Learn more about your ad choices. Visit megaphone.fm/adchoices